Allworth Financial’s Alto Neuroscience ANRO Stock Holding History

Allworth Financial’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17	Closed	-$195	–	4054
2024 Q3	$195	Buy	+17	New	+$208	﹤0.01%	3601

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Allworth Financial's ANRO Position: Q4 2024 in Review

Allworth Financial sold out of Alto Neuroscience (ANRO) in Q4 2024, closing a stake of 17 shares — an estimated $195 sold.

Allworth Financial first reported a position in ANRO in Q3 2024 and held it in 1 quarter. The position peaked at $195 in Q3 2024. 77 funds tracked by Wall St. Rank hold ANRO as of Q4 2024.

Allworth Financial reported no remaining Alto Neuroscience position as of Q4 2024 after selling out during the quarter.
Allworth Financial sold 17 Alto Neuroscience shares in Q4 2024, an estimated $195.
Allworth Financial first reported a position in Alto Neuroscience in Q3 2024 and held it in 1 quarter.
Allworth Financial's Alto Neuroscience position peaked at $195 in Q3 2024.
77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2024.

Based on Allworth Financial's 13F filing for Q4 2024, filed 30 Jan 2025.